Biogen has entered into a definitive merger agreement to acquire Apellis Pharmaceuticals as of March 31, 2026. This major acquisition will require significant capital and trigger extensive post-merger integration activities, creating needs for consulting, IT systems consolidation, and organizational restructuring services.
Filing excerpt
Agreement and Plan of Merger, dated as of March 31, 2026, by and among Apellis Pharmaceuticals, Inc., Biogen Inc. and Aspen Purchaser Sub, Inc. Filed as Exhibit 2.1 to our Current Report on Form 8-K filed on March 31, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Competitors named
sec-10qcapexIncreaseGet every 10-Q signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/363bc354-3d55-4500-a1a8-5971877a59c5 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "363bc354-3d55-4500-a1a8-5971877a59c5",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-05T08:48:22.649+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen has entered into a definitive merger agreement to acquire Apellis Pharmaceuticals as of March 31, 2026. This major acquisition will require significant capital and trigger extensive post-merger integration activities, creating needs for consulting, IT systems consolidation, and organizational restructuring services.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Merger and acquisition activity"
},
"summary": "Biogen to acquire Apellis Pharmaceuticals in a major merger agreement.",
"excerpts": "Agreement and Plan of Merger, dated as of March 31, 2026, by and among Apellis Pharmaceuticals, Inc., Biogen Inc. and Aspen Purchaser Sub, Inc. Filed as Exhibit 2.1 to our Current Report on Form 8-K filed on March 31, 2026.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000045/biib-20260331.htm",
"filing_date": "2026-04-29",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Budget available",
"signal_category": "financial",
"competitors_mentioned": [
"Apellis Pharmaceuticals, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/363bc354-3d55-4500-a1a8-5971877a59c5 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.